Evidence-based medicine was bound to fail: a report to Alvan Feinstein

Journal of Clinical Epidemiology

Volumn 84, Issue , 2017, Pages 3-7

  Fava, Giovanni A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b ERIE COUNTY MEDICAL CENTER   (United States)

Author keywords

Clinimetrics; Conflict of interest; Evidence based medicine

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; HISTORY; METHODOLOGY;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HUMANS; RESEARCH DESIGN;

EID: 85019352337     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2017.01.012     Document Type: Note

References (20)

1. Ioannidis, J.P.A., Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol 73 (2016), 82–86.
2. Engel, G.L., The need for a new medical model: a challenge for biomedicine. Science 196 (1977), 129–136.
3. Fava, G.A., The hidden costs of financial conflicts of interest in medicine. Psychother Psychosom 85 (2016), 65–70.
4. Engel, G.L., Physician scientists and scientific physicians. Am J Med 82 (1987), 107–111.
5. Feinstein, A.R., The intellectual crisis in clinical science. Persp Biol Med 30 (1987), 215–230.
6. Feinstein, A.R., Clinimetrics. 1987, Yale University Press, New Haven, CT.
7. Fava, G.A., Tomba, E., Sonino, N., Clinimetrics: the science of clinical measurements. Int J Clin Pract 66 (2012), 11–15.
8. Feinstein, A.R., Horwitz, R.I., Problems in the “evidence” of “evidence-based medicine”. Am J Med 103 (1997), 529–535.
9. Feinstein, A.R., Meta-analysis: statistical alchemy for the 21st century. J Clin Epidemiol 48 (1995), 71–79.
10. Jane-Wit, D., Horwitz, R.I., Concato, J., Variation in results from randomized, controlled trials: stochastic or systematic?. J Clin Epidemiol 63 (2010), 56–63.
11. Fava, G.A., Guidi, J., Rafanelli, C., Sonino, N., The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom 84 (2015), 1–3.
12. Reuben, D.B., Tinetti, M.E., Goal-oriented patient care- an alternative health outcomes paradigm. N Engl J Med 366 (2012), 777–779.
13. Offidani, E., Guidi, J., Tomba, E., Fava, G.A., Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom 82 (2013), 355–362.
14. Ebrahin, S., Bance, S., Athalke, A., Malachowski, C., Ioannidis, J.P.A., Meta-analyses with industry involvement are massively published and report no caveats for antidepressants. J Clin Epidemiol 70 (2016), 155–163.
15. Fava, G.A., Gatti, A., Belaise, C., Guidi, J., Offidani, E., Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation. Psychother Psychosom 84 (2015), 63–71.
16. Horwitz, R.I., Singer, B.H., Makuch, R.W., Viscoli, C.M., Can treatment that is helpful on average be harmful to some patients?. J Clin Epidemiol 49 (1996), 395–400.
17. Richardson, W.S., Doster, L.M., Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. J Clin Epidemiol 67 (2014), 244–246.
18. Vanderbroucke, J.P., Psaty, B.M., Benefits and risks of drug treatments. How to combine the best evidence on benefits with the best data about adverse effects. JAMA 300 (2008), 2417–2419.
19. Feinstein, A.R., Clinical judgment. 1967, Williams & Wilkins, Baltimore, MD.
20. Engel, G.L., How much longer must medicine's science be bound by a seventeenth century world view?. Psychother Psychosom 57 (1992), 3–16.